Chapter
The History of MDMA and MAPS
1:24:13 - 1:30:34 (06:20)
In this podcast episode, the founder of MAPS (Multidisciplinary Association for Psychedelic Studies) discusses the history of MDMA and how it led to the creation of MAPS as a nonprofit pharmaceutical company to change attitudes towards therapeutic drug use in America.
Clips
The use of psychedelics as therapy drugs has been the subject of debate due to the risks and benefits involved.
1:24:13 - 1:27:00 (02:46)
Summary
The use of psychedelics as therapy drugs has been the subject of debate due to the risks and benefits involved. While some researchers have fudged data to justify their use, others have underplayed the risks associated with these drugs.
ChapterThe History of MDMA and MAPS
Episode#202 – Rick Doblin: Psychedelics
PodcastLex Fridman Podcast
MAPS was founded in 1986 as a nonprofit pharmaceutical company to challenge the government's narrative on therapeutic drug use.
1:27:00 - 1:29:25 (02:25)
Summary
MAPS was founded in 1986 as a nonprofit pharmaceutical company to challenge the government's narrative on therapeutic drug use. Psychedelic therapy, such as MDMA, has proved to be a successful tool in easing human suffering and changing attitudes towards drug usage.
ChapterThe History of MDMA and MAPS
Episode#202 – Rick Doblin: Psychedelics
PodcastLex Fridman Podcast
Rick Doblin, founder of MAPS, shares his journey in creating a non-profit pharmaceutical company focused on the medical benefits of psychedelics, and the challenges he faced in obtaining necessary funds and changing public opinion on drug policy reform.
1:29:25 - 1:30:34 (01:08)
Summary
Rick Doblin, founder of MAPS, shares his journey in creating a non-profit pharmaceutical company focused on the medical benefits of psychedelics, and the challenges he faced in obtaining necessary funds and changing public opinion on drug policy reform.